Cargando…
Clinical Treatment Study of Secondary Multiple Squamous Cell Carcinoma with Psoriasis Vulgaris
Dermatologic diseases are the fourth most frequent nonfatal common illness, yet they have a psychological, economical, and professional burden that is comparable to or larger than other chronic conditions. From a survey in China of 6 provinces, the overall prevalence of psoriasis with squamous cell...
Autores principales: | Han, Sai-Nan, Feng, Shi-Jun, Ai, Dong-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758264/ https://www.ncbi.nlm.nih.gov/pubmed/35035485 http://dx.doi.org/10.1155/2022/9529681 |
Ejemplares similares
-
Multiple drugs: COVID-19, psoriasis vulgaris flare-up and exacerbation of psoriasis vulgaris led to erythrodermic psoriasis: 2 case reports
Publicado: (2022) -
Calcipotriol/betamethasone dipropionate in the treatment of psoriasis vulgaris
por: Vakirlis, Efstratios, et al.
Publicado: (2008) -
Rheumatoid Arthritis and Psoriasis Vulgaris
por: Boisvert, Paul L.
Publicado: (1956) -
Pulmonary fibrosis developed secondary to methotrexate use in a patient with psoriasis vulgaris
por: Karadag, Ayse Serap, et al.
Publicado: (2015) -
Gelsolin as a Potential Clinical Biomarker in Psoriasis Vulgaris
por: Lee, Sul Hee, et al.
Publicado: (2023)